Filing Details

Accession Number:
0001179110-10-005386
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-03-16 13:00:00
Reporting Period:
2010-03-12
Filing Date:
2010-03-16
Accepted Time:
2010-03-16 16:36:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
884629 Watson Pharmaceuticals Inc WPI Pharmaceutical Preparations (2834) 953872914
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1241752 D Charles Ebert C/O Watson Pharmaceuticals, Inc.
311 Bonnie Circle
Corona CA 92880
Sr. Vp, Research & Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0033 Acquisiton 2010-03-12 1,600 $38.92 31,869 No 4 M Direct
Common Stock, Par Value $0.0033 Acquisiton 2010-03-12 6,400 $38.92 38,269 No 4 M Direct
Common Stock, Par Value $0.0033 Acquisiton 2010-03-12 4,843 $26.14 43,112 No 4 M Direct
Common Stock, Par Value $0.0033 Acquisiton 2010-03-12 8,757 $26.14 51,869 No 4 M Direct
Common Stock, Par Value $0.0033 Acquisiton 2010-03-12 316 $35.11 52,185 No 4 M Direct
Common Stock, Par Value $0.0033 Acquisiton 2010-03-12 3,684 $35.11 55,869 No 4 M Direct
Common Stock, Par Value $0.0033 Acquisiton 2010-03-12 1,001 $25.64 56,870 No 4 M Direct
Common Stock, Par Value $0.0033 Acquisiton 2010-03-12 1,999 $25.64 58,869 No 4 M Direct
Common Stock, Par Value $0.0033 Disposition 2010-03-12 1,200 $40.88 57,669 No 4 S Direct
Common Stock, Par Value $0.0033 Disposition 2010-03-12 1,500 $40.86 56,169 No 4 S Direct
Common Stock, Par Value $0.0033 Disposition 2010-03-12 850 $40.87 55,319 No 4 S Direct
Common Stock, Par Value $0.0033 Disposition 2010-03-12 200 $40.88 55,119 No 4 S Direct
Common Stock, Par Value $0.0033 Disposition 2010-03-12 200 $40.87 54,919 No 4 S Direct
Common Stock, Par Value $0.0033 Disposition 2010-03-12 24,650 $40.85 30,269 No 4 S Direct
Common Stock, Par Value $0.0033 Disposition 2010-03-14 1,265 $41.37 29,004 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $0.0033 Non-Qualified Options to Purchase Common Stock Disposition 2010-03-12 1,600 $0.00 1,600 $38.92
Common Stock, Par Value $0.0033 Non-Qualified Options to Purchase Common Stock Disposition 2010-03-12 6,400 $0.00 6,400 $38.92
Common Stock, Par Value $0.0033 Incentive Stock Options to Purchase Common Stock Disposition 2010-03-12 4,843 $0.00 4,843 $26.14
Common Stock, Par Value $0.0033 Non-Qualified Options to Purchase Common Stock Disposition 2010-03-12 8,757 $0.00 8,757 $26.14
Common Stock, Par Value $0.0033 Incentive Stock Options to Purchase Common Stock Disposition 2010-03-12 316 $0.00 316 $35.11
Common Stock, Par Value $0.0033 Non-Qualified Options to Purchase Common Stock Disposition 2010-03-12 3,684 $0.00 3,684 $35.11
Common Stock, Par Value $0.0033 Incentive Stock Options to Purchase Common Stock Disposition 2010-03-12 1,001 $0.00 1,001 $25.64
Common Stock, Par Value $0.0033 Non-Qualified Options to Purchase Common Stock Disposition 2010-03-12 1,999 $0.00 1,999 $25.64
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2005-12-15 2013-08-04 No 4 M Direct
0 2005-12-15 2013-08-04 No 4 M Direct
0 2009-08-09 2014-08-09 No 4 M Direct
3,400 2008-08-09 2014-08-09 No 4 M Direct
0 2009-08-12 2015-08-12 No 4 M Direct
0 2009-08-12 2015-08-12 No 4 M Direct
1,000 2009-09-01 2016-09-01 No 4 M Direct
0 2009-09-01 2016-09-01 No 4 M Direct
Footnotes
  1. Includes shares of restricted stock issued pursuant to the Second Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.